Literature DB >> 19329437

Domain swapping reveals that low density lipoprotein (LDL) type A repeat order affects ligand binding to the LDL receptor.

Taichi Yamamoto1, Robert O Ryan.   

Abstract

The low density lipoprotein receptor (LDLR) plays a key role in plasma cholesterol homeostasis by binding and internalizing lipoprotein ligands. Studies have revealed that one or more of the seven LDL type A repeats (LA1-LA7) in the receptor are responsible for apolipoprotein binding. In the present study, protein engineering was performed to swap or replace key LA repeats in a recombinant soluble LDLR (sLDLR). Although wild type sLDLR showed strong ligand binding activity, an sLDLR variant in which LA repeat 5 was replaced by a second copy of LA repeat 2 showed low binding activity. Likewise, a variant wherein LA repeats 2 and 5 were swapped displayed low binding activity. At the same time, substitution of LA repeat 2 with a second a copy of repeat 5 resulted in a receptor with ligand binding activity similar to wild type LDLR. When binding assays were conducted with human low density lipoprotein as ligand, LA repeat order was a less important determinant of binding activity. Taken together, the data indicate that the sequential order of LA repeats plays a key role in ligand binding properties of LDLR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329437      PMCID: PMC2679439          DOI: 10.1074/jbc.M900194200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Role of leucine zipper motif in apoE3 N-terminal domain lipid binding activity.

Authors:  Taichi Yamamoto; Robert O Ryan
Journal:  Biochim Biophys Acta       Date:  2006-07-21

2.  LDL receptor family: isolation, production, and ligand binding analysis.

Authors:  Tarek M Bajari; Vera Strasser; Johannes Nimpf; Wolfgang Johann Schneider
Journal:  Methods       Date:  2005-06       Impact factor: 3.608

Review 3.  Human low-density lipoprotein receptor gene and its regulation.

Authors:  Wei-Jia Kong; Jingwen Liu; Jian-Dong Jiang
Journal:  J Mol Med (Berl)       Date:  2005-11-16       Impact factor: 4.599

4.  Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module.

Authors:  D Fass; S Blacklow; P S Kim; J M Berger
Journal:  Nature       Date:  1997-08-14       Impact factor: 49.962

5.  Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins.

Authors:  D W Russell; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

6.  The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  J Biol Chem       Date:  2008-08-03       Impact factor: 5.157

7.  Mutational analysis of the ligand binding domain of the low density lipoprotein receptor.

Authors:  V Esser; L E Limbird; M S Brown; J L Goldstein; D W Russell
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

8.  Molecular studies of pH-dependent ligand interactions with the low-density lipoprotein receptor.

Authors:  Taichi Yamamoto; Hsuan-Chih Chen; Emmanuel Guigard; Cyril M Kay; Robert O Ryan
Journal:  Biochemistry       Date:  2008-10-11       Impact factor: 3.162

9.  Characterization of low density lipoprotein receptor ligand interactions by fluorescence resonance energy transfer.

Authors:  Taichi Yamamoto; Johanne Lamoureux; Robert O Ryan
Journal:  J Lipid Res       Date:  2006-02-08       Impact factor: 5.922

10.  PCSK9: a convertase that coordinates LDL catabolism.

Authors:  Jay D Horton; Jonathan C Cohen; Helen H Hobbs
Journal:  J Lipid Res       Date:  2008-11-19       Impact factor: 5.922

View more
  7 in total

1.  Role of an intramolecular contact on lipoprotein uptake by the LDL receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochim Biophys Acta       Date:  2011-04-09

2.  Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.

Authors:  Laurent Vergnes; Jessica M Lee; Robert G Chin; Johan Auwerx; Karen Reue
Journal:  Cell Metab       Date:  2013-06-04       Impact factor: 27.287

3.  The structure, dynamics, and binding of the LA45 module pair of the low-density lipoprotein receptor suggest an important role for LA4 in ligand release.

Authors:  Miklos Guttman; Elizabeth A Komives
Journal:  Biochemistry       Date:  2011-11-29       Impact factor: 3.162

4.  Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome.

Authors:  Alexey Kolyada; Andrew Porter; Natalia Beglova
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

5.  Interaction between SCO-spondin and low density lipoproteins from embryonic cerebrospinal fluid modulates their roles in early neurogenesis.

Authors:  América Vera; Antonia Recabal; Natalia Saldivia; Karen Stanic; Marcela Torrejón; Hernán Montecinos; Teresa Caprile
Journal:  Front Neuroanat       Date:  2015-05-28       Impact factor: 3.856

6.  Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography.

Authors:  Wen-Jane Lee; Han-Ni Chuang; Yi-Ming Chen; Kae-Woei Liang; Hsin Tung; Jun-Peng Chen; I-Te Lee; Jun-Sing Wang; Ching-Heng Lin; Hsueh-Ju Lin; Wayne Huey-Herng Sheu; Wen-Lieng Lee; Tzu-Hung Hsiao
Journal:  Genes (Basel)       Date:  2021-09-14       Impact factor: 4.096

Review 7.  SCO-spondin, a giant matricellular protein that regulates cerebrospinal fluid activity.

Authors:  Vania Sepúlveda; Felipe Maurelia; Maryori González; Jaime Aguayo; Teresa Caprile
Journal:  Fluids Barriers CNS       Date:  2021-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.